Protagonist Therapeutics Inc (PTGX)
Inventory turnover
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 39,796 | 33,491 | 32,071 | 31,310 | 29,829 | 31,739 | 32,367 | 32,722 | 31,746 | 27,196 | 24,930 | 22,565 | 20,027 | 18,638 | 17,751 | 16,875 | 16,561 | 15,749 | 15,159 | 14,505 |
Inventory | US$ in thousands | — | — | -2,050 | -50 | -51 | -94 | -620 | — | 7,729 | 8,503 | — | — | — | 3,976 | 10 | 10 | 10 | 4,795 | 10 | 10 |
Inventory turnover | — | — | — | — | — | — | — | — | 4.11 | 3.20 | — | — | — | 4.69 | 1,775.10 | 1,687.50 | 1,656.10 | 3.28 | 1,515.90 | 1,450.50 |
March 31, 2024 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $39,796K ÷ $—K
= —
Inventory turnover for Protagonist Therapeutics Inc has shown fluctuations over the past quarters, indicating varying efficiencies in managing its inventory. The company's inventory turnover ratio ranged from a low of 1.515.90 in September 2019 to a high of 1,775.10 in September 2020. Notably, the high turnover in September 2020 may suggest that the company effectively sold through its inventory multiple times during that period.
It is important to highlight the extreme values observed in 2020, specifically in March and September. These values, notably 1,775.10 and 1,687.50, may be outliers or data errors given the substantial deviation from the typical ranges of inventory turnover ratios seen in the industry.
Additionally, the inventory turnover ratio for the most recent quarters (up to March 2022) fell within the range of 3.20 to 4.69, indicating that the company has shown relatively consistent inventory management efficiency during this period. However, the absence of data for some quarters in between further limits the ability to track the trend of inventory turnover over time.
Overall, Protagonist Therapeutics Inc should aim to maintain a steady and optimal level of inventory turnover to ensure effective management of its inventory and efficient operations.
Peer comparison
Mar 31, 2024
Mar 31, 2024